Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease

Chung, Kenny K.K., Zhang, Yi, Lim, Kah Leong, Tanaka, Yuji, Huang, Hui, Gao, Jun, Ross, Christopher A., Dawson, Valina L. +1 more·2001·Nature Medicine
DOI 10.1038/nm1001-1144

Cited by (744)

Items 401–500 of 744

  1. Interactogeneous: Disease Gene Prioritization Using Heterogeneous Networks and Full Topology Scores
    Joana P. Gonçalves, Alexandre P. Francisco, Yves Moreau, Sara Cordeiro Madeira · 2012 · PLoS ONE
  2. Cannabinoid CB1 receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice
    Sara Rodrigo González, María A. Mena, Isabel Lastres‐Becker, Alba Serrano, Justo Garcı́a de Yébenes, José Antonio Ramos, Javier Fernández‐Ruíz · 2005 · Brain Research
  3. Ubiquitin domain proteins in disease
    Louise Madsen, Andrea Schulze, Michael Seeger, Rasmus Hartmann‐Petersen · 2007 · BMC Biochemistry
  4. The Cell Biology of α Synuclein
    Nelson B. Cole, Diane D. Murphy · 2002 · NeuroMolecular Medicine
  5. Synphilin-1 alters metabolic homeostasis in a novel Drosophila obesity model
    Jihan Liu, T Li, Dejun Yang, Rui Ma, Timothy H. Moran, Wanli W. Smith · 2012 · International Journal of Obesity
  6. Why would Parkinson’s disease lead to sudden changes in creativity, motivation, or style with visual art?: A review of case evidence and new neurobiological, contextual, and genetic hypotheses
    Jon O. Lauring, Tomohiro Ishizu, Hana H. Kutlikova, Felix Dörflinger, Steven Haugbøl, Helmut Leder, Ron C. Kupers, Matthew J. Pelowski · 2019 · Neuroscience & Biobehavioral Reviews
  7. Nicotine suppresses Parkinson’s disease like phenotypes induced by Synphilin-1 overexpression in Drosophila melanogaster by increasing tyrosine hydroxylase and dopamine levels
    Angel Carvajal-Oliveros, Carmen Domínguez-Baleón, Rafaella V. Zárate, Jorge M. Campusano, Verónica Narváez‐Padilla, Enrique Reynaud · 2021 · Scientific Reports
  8. The roles of the proteasome pathway in signal transduction and neurodegenerative diseases
    Jiaojiao Chen, Fang Lin, Zheng‐Hong Qin · 2008 · Neuroscience Bulletin
  9. Synphilin-1A Inhibits Seven in Absentia Homolog (SIAH) and Modulates α-Synuclein Monoubiquitylation and Inclusion Formation
    Raymonde Szargel, Ruth Rott, Allon Eyal, Joseph Haskin, Vered Shani, Livia Balan, Herman Wolosker, Simone Engelender · 2009 · Journal of Biological Chemistry
  10. The neuronal ubiquitin-proteasome system: Murine models and their neurological phenotype
    Paula van Tijn, Elly M. Hol, Fred W. van Leeuwen, David F. Fischer · 2008 · Progress in Neurobiology
  11. ? - synuclein and Parkinson's disease: the first roadblock
    Christelle En Lin Chua, Bor Luen Tang · 2006 · Journal of Cellular and Molecular Medicine
  12. Genome-wide screen for modifiers of Parkinson's disease genes in Drosophila
    Caroline Fernandes, Yong Rao · 2011 · Molecular Brain
  13. The interplay between parkin and alpha-synuclein; possible implications for the pathogenesis of Parkinson’s disease
    Henryk M. Jęśko, Anna M. Lenkiewicz, Anna Wilkaniec, Agata Adamczyk · 2019 · Acta Neurobiologiae Experimentalis
  14. Transgenic overexpression of the alpha-synuclein interacting protein synphilin-1 leads to behavioral and neuropathological alterations in mice
    Silke Nuber, Thomas Franck, Hartwig Wolburg, Ulrike Schumann, Nicolas Casadei, Kristina Fischer, Carsten Calaminus, Bernd Jürgen Pichler, Sittinan Chanarat, Peter Teismann et al. · 2009 · Neurogenetics
  15. Synphilin-1 isoforms in Parkinson’s disease: regulation by phosphorylation and ubiquitylation
    Raymonde Szargel, R. Rott, Simone Engelender · 2007 · Cellular and Molecular Life Sciences
  16. p32 regulates mitochondrial morphology and dynamics through parkin
    Y. Li, Oi Wan Wan, W. Xie, Kenny K. K. Chung · 2011 · Neuroscience
  17. Ubiquitinated inclusions and neuronal cell death.
    Isabelle Lang‐Rollin, Hardy J. Rideout, Leonidas Stefanis · 2003 · PubMed
  18. Selective multifaceted E3 ubiquitin ligases barricade extreme defense: Potential therapeutic targets for neurodegeneration and ageing
    Arun Upadhyay, Ayeman Amanullah, Deepak Chhangani, Ribhav Mishra, Amit Mishra · 2015 · Ageing Research Reviews
  19. The role of E3 ubiquitin ligases in synapse function in the healthy and diseased brain
    Hiroshi Kawabe, Judith Stegmüller · 2021 · Molecular and Cellular Neuroscience
  20. Programmed cell death and new discoveries in the genetics of parkinsonism
    Robert E. Burke · 2008 · Journal of Neurochemistry
  21. Parkin Suppresses c-Jun N-terminal kinase-induced cell death via transriptional regulation in Drosophila
    Soojin Hwang, Darae Kim, Gahee Choi, Seon Woo A. An, Yoon Ki Hong, Yoon Seak Suh, Min Jung Lee, Kyoung Sang Cho · 2010 · Molecules and Cells
  22. Ultrastructural localization of parkin in the rat brainstem, thalamus and basal ganglia
    Annick Prigent, Marie‐Paule Muriel, Wen‐Jie Gu, Khalid Hamid El Hachimi, C. B. L�cking, Alexis Brice, Étienne C. Hirsch · 2004 · Journal of Neural Transmission
  23. Neurological disease: UPS stops delivering!
    Richard J. Miller, Scott M. Wilson · 2002 · Trends in Pharmacological Sciences
  24. The genetics of Parkinson’s disease
    Kah Leong Lim, Valina Lynn Dawson, Ted M. Dawson · 2002 · Current Neurology and Neuroscience Reports
  25. Telmisartan Reduces Progressive Oxidative Stress and Phosphorylated α-Synuclein Accumulation in Stroke-resistant Spontaneously Hypertensive Rats after Transient Middle Cerebral Artery Occlusion
    Kota Sato, Toru Yamashita, Tomoko Kurata, Violeta Lukic, Yusuke Fukui, Nozomi Hishikawa, Kentaro Deguchi, Koji Abe · 2014 · Journal of Stroke and Cerebrovascular Diseases
  26. The role of synphilin-1 in synaptic function and protein degradation
    Rejko Krüger · 2004 · Cell and Tissue Research
  27. The Nigral Coup in Parkinson’s Disease by α-Synuclein and Its Associated Rebels
    Jeswinder Sian‐Hülsmann, Peter Franz Riederer · 2021 · Cells
  28. SNCA , a novel biomarker for Group 4 medulloblastomas, can inhibit tumor invasion and induce apoptosis
    Yongxiao Li, Zhen‐Wei Yu, Tao Jiang, Li‐Wei Shao, Yan Liu, Na Li, Yu‐Feng Wu, Chen Zheng, Xiao‐Yu Wu, Ming Zhang et al. · 2018 · Cancer Science
  29. The impact of genetic research on our understanding of Parkinson’s disease
    Ian Martin, Valina Lynn Dawson, Ted M. Dawson · 2010 · Progress in brain research
  30. Developmental exposure to organophosphates triggers transcriptional changes in genes associated with Parkinson's disease in vitro and in vivo
    Theodore A. Slotkin, Frederic J. Seidler · 2011 · Brain Research Bulletin
  31. The role of protein aggregates in neuronal pathology: guilty, innocent, or just trying to help?
    Suzana Gispert-Sánchez, Georg W. J. Auburger · 2006 · Springer eBooks
  32. Recent Advances in Research on Parkinson Disease: Synuclein and Parkin
    Robert E. Burke · 2004 · The Neurologist
  33. Linking ubiquitin, parkin and synphilin-1
    Aaron J. Ciechanover · 2001 · Nature Medicine
  34. AF-6 is a positive modulator of the PINK1/parkin pathway and is deficient in Parkinson's disease
    Joseph Haskin, Raymonde Szargel, Vered Shani, Lucy N. Mekies, R. Rott, G. G. Y. Lim, Kah‐Leong Lim, Rina Bandopadhyay, Herman Wolosker, Simone Engelender · 2013 · Human Molecular Genetics
  35. Roles of peptidyl-prolyl isomerase Pin1 in disease pathogenesis
    Jingyi Li, Chunfen Mo, Yifan Guo, Bowen Zhang, Xiao Feng, Qiuyue Si, Xiaobo Wu, Zhe Zhao, Lixin Gong, Dan He et al. · 2021 · Theranostics
  36. The Role of NEDD4 E3 Ubiquitin–Protein Ligases in Parkinson’s Disease
    James A. Conway, Grant Kinsman, Edgar R. Kramer · 2022 · Genes
  37. Parkin Co-Regulated Gene is involved in aggresome formation and autophagy in response to proteasomal impairment
    Juliet Marie Taylor, Kate Maree Brody, Paul J. Lockhart · 2012 · Experimental Cell Research
  38. Potential Role of Caffeine in the Treatment of Parkinson’s Disease
    Mohsin H. K. Roshan, Amos Tambo, Nikolai Paul Pace · 2016 · The Open Neurology Journal
  39. Effects of Intrinsic and Extrinsic Factors on Aggregation of Physiologically Important Intrinsically Disordered Proteins
    Leonid Breydo, Jennifer Redington, Vladimir Nikolaevich Uversky · 2016 · International review of cytology
  40. New Aspects of Genetic Contributions to Parkinson's Disease
    Anne Hofer, Thomas Gasser · 2004 · Journal of Molecular Neuroscience
  41. Effect of an experimental proteasome inhibitor on the cytoskeleton, cytosolic protein turnover, and induction in the neuronal cells in vitro
    Vilmos Csizmadia · 2007 · NeuroToxicology
  42. New Directions in Gaucher Disease
    Mia Horowitz, Deborah Elstein, Ari Zimran, Özlem Göker-Alpan · 2016 · Human Mutation
  43. Cerebrospinal Fluid Metabolome in Parkinson’s Disease and Multiple System Atrophy
    Do Hyeon Kwon, Ji Su Hwang, Seok Gi Kim, Yong Eun Jang, Tae Hwan Shin, Gwang Lee · 2022 · International Journal of Molecular Sciences
  44. Canthin-6-One Accelerates Alpha-Synuclein Degradation by Enhancing UPS Activity: Drug Target Identification by CRISPR-Cas9 Whole Genome-Wide Screening Technology
    Ning-Ning Yuan, Cui-Zan Cai, Ming-Yue Wu, Qi Zhu, Huanxing Su, Min Li, Jiaoyan Ren, Jieqiong Tan, Jiahong Lu · 2019 · Frontiers in Pharmacology
  45. Progress in familial Parkinson’s disease
    Yoshikuni Mizuno, Nobutaka Hattori, H. Yoshino, Y. Hatano, Keigo Satoh, Hiroyuki Tomiyama, Yuanzhe Li · 2006 · Springer eBooks
  46. Tau and Parkinson Disease
    Maria Grazia Spillantini · 2001 · JAMA
  47. Polyubiquitination of apurinic/apyrimidinic endonuclease 1 by Parkin
    Timothy L. Scott, Christina A. Wicker, Suganya Rangaswamy, Bithika Dhar, Thomas A. Pittman, Craig Horbinski, Tadahide Izumi · 2016 · Molecular Carcinogenesis
  48. The serine protease HtrA2/Omi cleaves Parkin and irreversibly inactivates its E3 ubiquitin ligase activity
    Hye Min Park, Goo-Young Kim, Min‐Kyung Nam, Geun-Hye Seong, Chul Han, Kwang Chul Chung, Seongman Kang, Hyangshuk Rhim · 2009 · Biochemical and Biophysical Research Communications
  49. Impact of Autosomal Recessive Juvenile Parkinson’s Disease Mutations on the Structure and Interactions of the Parkin Ubiquitin-like Domain
    Susan S. Safadi, Kathryn R. Barber, Gary S. Shaw · 2011 · Biochemistry
  50. Synphilin suppresses α‐synuclein neurotoxicity in a Parkinson's disease Drosophila model
    René Hernández-Vargas, Luis Fonseca‐Ornelas, Ignacio López‐González, Juan R. Riesgo‐Escovar, Mario Zurita, Enrique Reynaud · 2011 · genesis
  51. Can overexpression of parkin provide a novel strategy for neuroprotection in Parkinson's disease?
    Ayşe Ulusoy, Deniz Kirik · 2008 · Experimental Neurology
  52. Mitochondrial translation initiation factor 3 gene polymorphism associated with Parkinson's disease
    Nadine Abahuni, Suzana Gispert, Peter Bauer, Olaf Rieß, Rejko Krüger, Tim Becker, Georg W. J. Auburger · 2007 · Neuroscience Letters
  53. α - synuclein and Parkinson's disease: the first roadblock
    Christelle En Lin Chua, Bor Luen Tang · 2006 · Journal of Cellular and Molecular Medicine
  54. Mechanisms of Disease II: Cellular Protein Quality Control
    Tiago F. Outeiro, Julie E. Tetzlaff · 2007 · Seminars in Pediatric Neurology
  55. α‐Synuclein Pathology in PRKN ‐Linked Parkinson's Disease: New Insights from a Blood‐Based Seed Amplification Assay
    Annika Kluge, Max Borsche, Linn Streubel-Gallasch, Tuğçe Gül, Susen Schaake, Alexander Balck, Jannik Prasuhn, Philip Campbell, Huw R. Morris, Anthony H.V. Schapira et al. · 2024 · Annals of Neurology
  56. 1‐Benzyl‐1,2,3,4‐tetrahydroisoquinoline binds with tubulin β, a substrate of parkin, and reduces its polyubiquitination
    Ryuki Kohta, Yaichiro Kotake, Takamitsu Hosoya, Toshiyuki Hiramatsu, Yuko Otsubo, Hiroko Koyama, Yuji Hirokane, Yuichi Yokoyama, Hirofumi Ikeshoji, Ken Oofusa et al. · 2010 · Journal of Neurochemistry
  57. Porcine Parkin: Molecular cloning of PARK2 cDNA, expression analysis, and identification of a splicing variant
    Ditte Bjerre, Lone Bruhn Madsen, Christian Bendixen, Knud Larsen · 2006 · Biochemical and Biophysical Research Communications
  58. Genetics of neurological disorders
    Mohammad Ali Faghihi, Salim Mottagui‐Tabar, Claes Wahlestedt · 2004 · Expert Review of Molecular Diagnostics
  59. Parkin expression in the developing mouse
    Kati Kühn, Xin‐Ran Zhu, Hermann Lübbert, Christine C. Stichel · 2004 · Developmental Brain Research
  60. Microarray expression analysis of gad mice implicates involvement of Parkinson's disease associated UCH-L1 in multiple metabolic pathways
    M Bonin, Sven Poths, Hitoshi Osaka, Y.-L Wang, Keiji Wada, Olaf Rieß · 2004 · Molecular Brain Research
  61. Protein degradation in Parkinson disease revisited: it’s complex
    Han Li, Ming Guo · 2009 · Journal of Clinical Investigation
  62. Historical perspective and progress on protein ubiquitination at glutamatergic synapses
    Angela M. Mabb · 2021 · Neuropharmacology
  63. Effect of D-Ala 2 GIP, a stable GIP receptor agonist on MPTP-induced neuronal impairments in mice
    Mahip K. Verma, Rajan Naresh Goel, Krishnadas Nandakumar, Kumar V.S. Nemmani · 2017 · European Journal of Pharmacology
  64. A palmitoylated RING finger ubiquitin ligase and its homologue in the brain membranes
    Kazuaki Araki, Meiko Kawamura, Toshiaki Suzuki, Noriyuki Matsuda, Daiji Kambe, Kyoko Ishii, Tomio Ichikawa, Toshiro Kumanishi, Tomoki Chiba, Keiji Tanaka et al. · 2003 · Journal of Neurochemistry
  65. Contribution of glutamatergic signaling to nitrosative stress‐induced protein misfolding in normal brain aging and neurodegenerative diseases
    Tomohiro Nakamura, Zezong Gu, Stuart A. Lipton · 2007 · Aging Cell
  66. Interplay between α-synuclein and parkin genes: Insights of Parkinson’s disease
    Kajal Sharma, Shivani Chib, Aniket Gupta, Randhir Singh, Rishabh Chalotra · 2024 · Molecular Biology Reports
  67. Synphilin-1 exhibits trophic and protective effects against Rotenone toxicity
    X. Li, Zhong Wu Liu, Kellie L. Tamashiro, B. Shi, Dobrila D. Rudnicki, C A Ross, Timothy H. Moran, W.W. Smith · 2009 · Neuroscience
  68. The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
    Lena F. Burbulla, Rejko Krüger · 2012 · Journal of Visualized Experiments
  69. Parkin Modulates Gene Expression in Control and Ceramide-Treated PC12 Cells
    Paul Gerson Unschuld, Justus C. Dächsel, Frederic D. Darios, Alexander Kohlmann, Elisabeth Casademunt, Klaus Lehmann‐Horn, Martin Dichgans, Merle Ruberg, Alexis Brice, Thomas Gasser et al. · 2006 · Molecular Biology Reports
  70. Regulation of Parkin expression as the key balance between neural survival and cancer cell death
    Fátima E. Murillo-González, Rosario García-Aguilar, Libia Vega, Guillermo Elizondo · 2021 · Biochemical Pharmacology
  71. The role of gamma‐synuclein in cocaine‐induced behaviour in rats
    Frédéric Boyer, Jean‐Luc Dreyer · 2008 · European Journal of Neuroscience
  72. Differential Interaction of the E3 Ligase Parkin with the Proteasomal Subunit S5a and the Endocytic Protein Eps15
    Susan S. Safadi, Gary S. Shaw · 2009 · Journal of Biological Chemistry
  73. Dementia with Lewy bodies
    James B. Leverenz, Ian Grant McKeith · 2002 · Medical Clinics of North America
  74. Parkin, A Top Level Manager in the Cells Sanitation Department
    Carolyn A. Rankin, Ambrish Roy, Yang Zhang, Mark L. Richter · 2011 · The Open Biochemistry Journal
  75. Altered Hippocampal Synaptic Physiology in Aged Parkin-Deficient Mice
    Jesse E. Hanson, Adrienne Orr, Daniel V. Madison · 2010 · NeuroMolecular Medicine
  76. Ubiquitin-protein ligase parkin and its role in the development of Parkinson’s disease
    О.А. Бунеева, A. E. Medvedev · 2006 · Biochemistry (Moscow)
  77. Lewy Body Disorders
    K. A. Jellinger · 2007 · Springer eBooks
  78. Familial Parkinson?s disease: a hint to elucidate the mechanisms of nigral degeneration
    Nobutaka Hattori, Hirokazu Kobayashi, 波田野 靖子, Kenichi Sato, Yoshikuni Mizuno · 2003 · Journal of Neurology
  79. Parkinson’s Genetics: Molecular Insights for the New Millennium
    Lisa M. Skipper, Matthew James Farrer · 2002 · NeuroToxicology
  80. Parkinson's Disease: Genetics and Pathogenesis
    Claudia M. Testa · 2007 · Wiley eBooks
  81. Arf6 Guanine Nucleotide Exchange Factor Cytohesin-2 Binds to CCDC120 and Is Transported Along Neurites to Mediate Neurite Growth
    Tomohiro Torii, Yuki Miyamoto, Kenji Tago, Kazunori Sango, Kazuaki Nakamura, Atsushi Sanbe, Akito Tanoue, Junji Yamauchi · 2014 · Journal of Biological Chemistry
  82. A genome-wide imaging-based screening to identify genes involved in synphilin-1 inclusion formation in Saccharomyces cerevisiae
    Lei Zhao, Qian Yang, Ju Zheng, Xuefeng Zhu, Xinxin Hao, Jia Mei Song, Tom Lebacq, Vanessa Franssens, Joris Winderickx, Thomas Nyström et al. · 2016 · Scientific Reports
  83. Aggresome formation and segregation of inclusions influence toxicity of α-synuclein and synphilin-1 in yeast
    Erwin Swinnen, Sabrina Büttner, Tiago F. Outeiro, Marie‐Christine Galas, Frank Madeo, Joris Winderickx, Vanessa Franssens · 2011 · Biochemical Society Transactions
  84. The Parkin-Like Human Homolog of Drosophila Ariadne-1 (HHARI) Can Induce Aggresome Formation in Mammalian Cells and Is Immunologically Detectable in Lewy Bodies
    Sangram S. Parelkar, Juan G. Cadena, Chul Kim, Zhaohui Wang, Rachel Sugal, Brooke Bentley, Luis A. Moral, H.C. Ardley, Lawrence M. Schwartz · 2011 · Journal of Molecular Neuroscience
  85. Genotype–phenotype correlation: Familial Parkinson disease
    Hideo Mori, Nobutaka Hattori, Yoshikuni Mizuno · 2003 · Neuropathology
  86. Molecular pathways and genetic aspects of Parkinson’s disease: from bench to bedside
    Mario Di Napoli, Imtiaz M. Shah, David Alan Stewart · 2007 · Expert Review of Neurotherapeutics
  87. Neurogenetics: insights into degenerative diseases and approaches to schizophrenia
    Christopher A. Ross, Russell L. Margolis · 2005 · Clinical Neuroscience Research
  88. Stable Isotope Labeling and Label-Free Proteomics of Drosophila parkin Null Mutants
    Zhiyin Xun, Thomas C. Kaufman, David E. Clemmer · 2009 · Journal of Proteome Research
  89. Genetic association study of synphilin-1in idiopathic Parkinson's disease
    Ronny Myhre, Helge Klungland, Matthew James Farrer, Jan Olav Aasly · 2008 · BMC Medical Genetics
  90. α-Synuclein ubiquitination – functions in proteostasis and development of Lewy bodies
    Hung-Hsiang Ho, Simon S. Wing · 2024 · Frontiers in Molecular Neuroscience
  91. Parkinson's disease: animal models
    Ranjita S. Betarbet, J. Timothy Greenamyre · 2007 · Handbook of clinical neurology
  92. Nuclear and Mitochondrial Genome, Epigenome and Gut Microbiome: Emerging Molecular Biomarkers for Parkinson’s Disease
    Gleyce Fonseca Cabral, Ana Paula Schaan, Giovanna C. Cavalcante, Camille Sena-dos-Santos, Tatiane Piedade de Souza, Natacha Medeiros de Souza Port’s, Jhully Azevedo dos Santos Pinheiro, Ândrea Ribeiro‐dos‐Santos, Amanda Ferreira Vidal · 2021 · International Journal of Molecular Sciences
  93. Molecular Mechanisms of Neurodegeneration in Parkinson's Disease: Clues from Mendelian Syndromes
    Kah Leong Lim, Tit Meng Lim · 2003 · IUBMB Life
  94. A novel obesity model: synphilin-1-induced hyperphagia and obesity in mice
    X Li, Kellie L. Tamashiro, Z Liu, Nicholas T. Bello, Xiaoqin Wang, Susan M. Aja, Sheng Bi, E. E. Ladenheim, Christopher A. Ross, Timothy H. Moran et al. · 2011 · International Journal of Obesity
  95. Ataxin-3 Is a Multivalent Ligand for the Parkin Ubl Domain
    Jane J. Bai, Susan S. Safadi, Pascal Mercier, Kathryn R. Barber, Gary S. Shaw · 2013 · Biochemistry
  96. Impairment of the ubiquitin–proteasome system associated with extracellular transthyretin aggregates in familial amyloidotic polyneuropathy
    Sofia Duque Santos, Isabel Cardoso, Joana Magalhães, Maria João Saraiva · 2007 · The Journal of Pathology
  97. A pragmatic approach to biochemical systems theory applied to an α-synuclein-based model of Parkinson's disease
    Matthew B. Sass, Alyson N. Lorenz, Robert L. Green, Randolph A. Coleman · 2008 · Journal of Neuroscience Methods
  98. hVMAT2: A Target of Individualized Medication for Parkinson's Disease
    Nian Xiong, Nuomin Li, Eden R. Martin, Jinlong Yu, Jie Li, Jing Liu, David Y.W. Lee, Ole Isacson A, Jeffery M. Vance, Hong Qing et al. · 2016 · Neurotherapeutics
  99. Reduction in endogenous parkin levels renders glial cells sensitive to both caspase‐dependent and caspase‐independent cell death
    Luci P. MacCormac, Miratul M. K. Muqit, David J. Faulkes, Nicholas William Wood, David S. Latchman · 2004 · European Journal of Neuroscience
  100. An Amish founder population reveals rare-population genetic determinants of the human lipidome
    May E. Montasser, Stella W. Aslibekyan, Vinodh Srinivasasainagendra, Hemant K. Tiwari, Amit Patki, Minoo Bagheri, Tobias Kind, Dinesh Kumar Barupal, Sili Fan, James A. Perry et al. · 2022 · Communications Biology